BEIJING, Feb. 23, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical
products, today announced that for the year ended December 31, 2011, it received subsidies of
RMB177,200 from the Chinese
government, led by the Ministry of Science and Technology of
China, the Ministry of Finance and
the State Administration of Taxation, as a result of the Company's
status as a High Technology Enterprise.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
According to the China Banking Regulatory Commission Guiding
Opinions Number 94, companies with high-tech status are eligible
for numerous potential benefits including preferential treatment in
obtaining other support from the government, competitive commercial
bank loans and subsidies for interest on bank loans.
The Company, which is based in Zhongguancun Science Park Beijing
Changping District, has benefitted from favorable tax treatment and
subsidies. As a certified high technology enterprise, Dehaier
is subject to an enterprise income tax rate of 15% tax rate
(compared to China's national 25%
tax rate) as long as it continues to be certified.
Mr. Ping Chen, Chairman and Chief
Executive Officer of Dehaier Medical stated, "As a smaller high
technology company, we are pleased with the strong support we
have received from the government. We continue to invest the
free cash flow from our business into further scientific research
and development, and we are committed to constantly improve our
products, and in turn, the lives of our patients."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents and five software
copyrights; additionally Dehaier has two pending software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's receipt of government
subsidies and other support and the likelihood to continue to
receive such support in the future. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, future developments in payment for and demand for
medical equipment and services, implementation of and performance
under the joint venture agreement by all parties, and other risks
contained in reports filed by the company with the Securities and
Exchange Commission. All such forward-looking statements, whether
written or oral, and whether made by or on behalf of the company,
are expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.